Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
Heart failure is spreading fast and hitting younger Americans harder than ever. A new report projects that 1 in 4 U.S. adults will develop heart failure in their lifetime, with prevalence rising from 3% today to 3.8% by 2050. Despite effective treatments existing, only 18% of eligible patients receive all four recommended therapies — a gap that could cost nearly 95,000 lives a year.
Heart failure (HF) is no longer just a condition of old age — it's becoming a growing crisis across all age groups. The Heart Failure Society of America's latest statistics report, published in the Journal of Cardiac Failure, projects that 1 in 4 U.S. adults (24%) will develop HF in their lifetime. Prevalence is expected to climb from 3% today to 3.8% by 2050, driven by an aging population and rising rates of obesity, hypertension, diabetes, and kidney disease.
Perhaps most alarming is the surge among younger adults. HF mortality rose 121% among adults aged 25–44 and 96% among those aged 45–64 between 2001 and 2020. Racial and geographic disparities are stark too — Black adults face hospitalization and mortality rates more than twice those of white adults, and HF burden is heaviest in the Deep South, Appalachia, and lower Midwest.
By the Numbers:
Why it matters: Effective, affordable treatments exist — but they're dramatically underused. Closing the implementation gap isn't just a clinical challenge; it's a public health and equity imperative with massive economic stakes.
